ABSTRACT. Effects of 2 and 4 pg/kg/min dopamine infusion on cardiovascular and renal functions, cerebral blood flow (CBF) and plasma catecholamine levels were studied in sick preterm neonates during the first four days of life. Preterm infants were found to have an enhanced responsiveness to the pressor effects of dopamine during this period. Comparison of the renal effects of 2 and 4 &kg/ min dopamine in 61 preterm infants indicate that 2 pg/kg/ min dopamine induces maximum diuresis and natriuresis during the first day of life provided that systemic blood pressure is within the predicted normal range. Although administration of 4 pg/kg/min dopamine induces further increases in blood pressure and glomerular filtration rate, urine output and sodium excretion remain similar to that on 2 pg/kg/min of the drug. These findings demonstrate that the direct tubular effects of dopamine play an important role in the diuretic and natriuretic action of the drug in the one-day old preterm infant. In five preterm neonates, changes in CBF transiently paralleled the dopamine-induced alterations in systemic blood pressure indicating that autoregulation of CBF is impaired but not completely ineffective in the one-day old preterm infant. In eight term neonates, increases in blood pressure had no effect on CBF. Measurements of plasma dopamine and norepinephrine levels in 14 preterm neonates and five children suggest that decreased metabolism of dopamine may contribute to the enhanced pressor responsiveness to dopamine in sick preterm infants. Based on these findings, we propose that dopamine should be started at 2 pg/kg/min in the hypotensive and/or oliguric preterm infant, and that the dose should be increased in a stepwise manner tailored to the cardiovascular and renal response to the patient. (Pediatr Res 34: 742449,1993) Abbreviations ACA, anterior cerebral artery ANOVA, analysis of variance CBF, cerebral blood flow 6, creatinine clearance DA, dopamine (study group) DBP, diastolic blood pressure EDFV, end-diastolic flow velocity ESFV, end-systolic flow velocity CFR, glomerular filtration rate
Hct, hematocrit IVH, intraventricular hemorrhage PI, pulsatility index SBP, systolic blood pressure UNHC urinary ammonium excretion UTA, titratable acidity Uv, urine output UUN, urea nitrogen excretion Dopamine has been the drug of choice to combat hypotension, impaired tissue perfusion and oliguria in critically ill neonates (1-5). Based mostly on extrapolation of data from findings in older infants and children, earlier studies have suggested that the minimally effective dose of dopamine in the sick term neonate is 10 to 15 pglkglmin (6,7). Furthermore, despite the differences between preterm and term infants in the maturation of their cardiovascular, renal, and endocrine systems, the minimally effective dose of dopamine for the preterm neonate has been assumed to be similar to that of the term infant (1). However, several recent reports indicate that lower doses of the drug may be effective in both term and preterm neonates (3-5). In addition, we have also suggested that the minimally effective cardiovascular dose of dopamine may be even lower in preterm than in term infants (3, 8, 9) . However, this enhanced cardiovascular responsiveness of the preterm infant to dopamine has not been confirmed.
The role of the drug-induced cardiovascular and renal hemodynamic changes in the renal effects of dopamine has been widely recognized in adults (10, I I) as well as in newborn infants (1, 2, 6) . Recent findings also demonstrate the importance of the direct tubular actions of dopamine in producing diuresis and natriuresis (9, (12) (13) (14) (15) (16) . However, it is not known whether immaturity of renal function in the preterm neonate affects the contribution of the direct tubular actions of dopamine to the drug-induced diuresis and natriuresis.
The pathogenesis of IVH and periventricular leukomalacia is almost certainly related to changes in cerebral hemodynamics ( 1 7-19). Because autoregulation of CBF in preterm neonates is impaired (20, 21), enhanced responsiveness of these infants to the pressor effects of dopamine may put them at risk for the development of IVH and/or periventricular leukomalacia. However, the effect of the dopamine-induced hemodynamic changes on CBF in the sick preterm infant has not been clarified. Furthermore, it is not known whether this effect changes with development.
The present study examines the effects of dopamine on cardi-
LOW-DOSE DOPAMINE AND PRETERM INFANTS

743
ovascular and renal functions, CBF, and plasma catecholamine two groups were published earlier (24) . Infants who required levels in sick preterm infants during the first days of life. We dopamine at a dose of 4 rg/kg/min to maintain appropriate compared cardiovascular and renal functions in preterm infants systemic blood pressures were assigned to the DA-4 group (n = with and without low-dose dopamine treatment. We also exam-10). The groups did not differ significantly in birth weight ( p = ined the changes in CBF during low-dose dopamine infusion in 0.072, ANOVA), gestational age ( p = 0.301, ANOVA), or unpreterm infants and compared the findings with those in term derlying diseases (Table 1) . Cardiovascular and renal function neonates. If responsiveness to the hemodynamic actions of do-data of the control group and the findings obtained in the DA-2 pamine is enhanced in preterm infants, several mechanisms and DA-4 groups during dopamine treatment are compared in could account for this phenomenon. These mechanisms include this segment of the study reflecting an unpaired study design. maturation-dependent differences in the order of adrenergic Infants in the control group manifested clinical signs of poor receptor sensitivity (22) , the unique hormonal milieu of preterm peripheral perfusion but had no systemic hypotension or signifinfants (I, 9,23), and immature metabolic function. We therefore icant oliguria (UV = 0.033 f 0.0 12 mL/min/kg). These patients also measured plasma dopamine clearance rates as a possible received I g/kg human albumin. Urine was collected for an 8-contributing mechanism to the proposed enhanced cardiovas-to 12-h period. Patients in the DA-2 group had oliguria and mild cular responsiveness to dopamine in the preterm infant.
systemic hypotension for at least I h before enrollment (Table  1) . These preterm infants received 1 g/kg human albumin fol-PATIENTS AND METHODS lowed by a dopamine infusion at a dose of 2 rg/kg/min. An 8-to 12-h urine collection was started when blood pressure stabiWe examined the effects of two doses of dopamine (2 versus lized on dopamine therapy (30 to 60 min after initiation of 4 pg/kg/min) on systemic blood pressure, renal function, CBF, dopamine treatment). Patients in the DA-4 group presented with and plasma catecholamine levels in sick preterm neonates. Stud-oliguria and systemic hypotension ( Table 1) . Infusion of 1-2 g/ ies on cardiovascular and renal function and CBF were per-kg human albumin resulted only in a transient increase in blood formed on the first day of life, whereas plasma catecholamine Pressure. Therefore, a dopamine infusion of 2 rg/kg/min was levels were measured during the first 4 d of life. In the studies on started and the dose was shortly increased to 4 ccg/kg/min to cardiovascular and renal function, normotensive preterm infants achieve blood pressures in the predicted normal range. At that served as controls, and oliguric and mildly or moderately hypo-time, an 8-to 12-h urine collection was initiated. Total crystalloid tensive preterm neonates requiring 2 or 4 @g/kg/min dopamine (60-80 mL/kg/d) administration was not different among the formed the two study groups (DA-2 and DA-4 groups, respec-groups during the first day of life. However, patients in the DAtively). In the studies on CBF, hypotensive preterm and term 4 group tended to receive more colloid than the infants in the neonates were studied and cardiovascular and CBF measure-two other groups (2 versus 1 g/kg albumin). merits were performed on both 2 and 4 rg/kg/min of dopamine.
At the midpoint of the 8-to 12-h urine collections, blood Thus, these patients also served as their own controls. In the samples were taken for plasma electrolyte, creatinine, and 0s-studies on plasma catecholamine levels, normotensive children molalit~ analysis. Urinary and plasma sodium, ~otassium, ~h o sreceiving 2 rg/kg/rnin dopamine served as controls and hypo-phorus, and creatinine were measured by standard laboratory tensive preterm neonates formed the study group. In the preterm techniques. UTA and U N H~ were determined from urine samples infants, measurements of plasma dopamine and norepinephrine taken under anaerobic conditions using ion-selective electrodes levels were performed on both 2 and 4 rg/kg/min dopamine. (24) . Urea nitrogen and osmolalit~ were measured by spectroPatients enrolled in the studies were cared for at the neonatal photometry and freezing point depression, respectively. Fratintensive care units of the 1st Department of Obstetrics/Gyne-ti0nd excretion of sodium and free Water clearance were calcucology and the 2nd Department of Pediatrics, Semmelweis Med-lated as described earlier (24) . ical School, Budapest, Hungary, and at the Division of Nephrol-CBF studies. CBF was n~easured in a separate group of five ogy, 1st Department of Pediatrics, Semmelweis Medical School. Preterm infants and eight term neonates. Clinical data and All the infants required ventilatory support in the form of nasal/ baseline SBP and DBP are shown in Table 2 . Patients were nasopharyngeal continuous positive airway pressure or intermit-enrolled who met the following criteria: 1 ) C24 h of age; 2 ) tent mandatory ventilation and received nothing by mouth at hypotension [SBP > 15 mm Hg below the predicted normal the time of the studies. Heart rate was monitored continuously value for gestational and postnatal age (25, 26) l; 3) 0 2 requireby conventional techniques. Blood pressure was measured either ment to maintain adequate arterial PO* with or without the need with oscillometry or from an umbilical artery catheter connected for mechanical ventilation; and 4) no significant change in pH, to a pressure transducer. Each data point of systolic and diastolic Pco2, Po2, heart rate, and Hct during the study. blood pressures is the average of two to three individual measChanges in ESFV and EDFV in the ACA as well as the urements. Routine supportive intensive care and monitoring of calculated PI [PI = ESFV -EDFV/ESFV (%) (27, 28) l were the patients were performed according to conventional guidelines used to assess changes in CBF during the study. ESFV and EDFV and clinical practice. In most of the patients, dopamine (Dopa-were measured by real-time duplex Doppler ultrasound and Mmin, Nattermann, Cologne, Germany) was infused into a pe-mode echocardiography (model: Picker LSC 7000, Picker, Inc., npheral vein by calibrated infusion pumps. In some neonates, Canton, MA). Scans were performed with 5-MHz transducers dopamine was administered centrally into the aorta or the infe-for real-time imaging and the Doppler studies. The ACA was nor vena cava through indwelling catheters. The five children (5 insonated through the anterior fontanel at its curve around the to I5 y of age) participating in the studies had mild renal diseases corpus callosum, where the angle of insonation is -0". Reliable with normal renal functions. blood flow velocity wave forms of the ACA with maximal The special techniques and analytical methods used in the amplitudes were obtained by optimizing the sample volume different segments of this study are described in detail below. position using acoustic and visual control. Arterial blood gases Informed parental consent was obtained in all cases and the and Hct values were obtained from indwelling arterial catheters. studies were approved by the institutional scientific committees. Heart rate, blood pressure, and Po2 were monitored as part of Cardiovascular and renal function studies. These studies were routine clinical care. Blood pressure measurements were perperformed on the first day of life in 6 1 preterm infants. Patients formed via oscillometry. were divided into three groups. Clinical data and baseline SBP, After baseline Doppler ultrasound measurements of CBF ve-DBP, and UV are shown in Table 1 . Infants in the control group locity and heart rate, blood pressure, and arterial blood gas (n = 21) did not receive dopamine therapy during the study, determinations (control data), dopamine infusion was begun at whereas patients in the DA-2 group (n = 3 1) received dopamine 2 pg/kg/min. Doppler ultrasound measurements and heart rate, infused at a rate of 2 rglkglmin. Renal function studies in these blood pressure, and arterial blood gas determinations were re- $Secondary to the low baseline UV, the changes in clinical condition, and thus the early need for treatment in the DA-2 and DA-4 groups, baseline Uv could not be accurately determined in all the patients. * GA, gestational age; HMD, hyaline membrane disease; TTN, tran-levels occurred (control data). Dopamine was then started at 2 sient tachypnea of the newborn; MAS, meconium aspiration syndrome. ~dkg/min. At this dose, 20 and 23 samples were analyzed for plasma dopamine and norepinephrine determinations, respecpeated at -20 min (range: 15 to 30 min, DA2/20 data) and -60 tively (DA-2 data). In 1 1 preterm neonates, the dose of dopamine min (range: 50 to 90 min, DA-2/60 data) during the infusion of was then increased to 4 pglkglmin to achieve the desired increase 2 pglkglrnin of dopamine. The dose of dopamine was then in systemic blood pressure (see Results). At this dose. 13 and 19 doubled, and all measurements were repeated at -20 min (range: 15 to 30 min) and -60 min (range: 50 to 90 min) (DA-4/20 and DA-4/60 data, respectively). In two infants, the dose ofdopamine had to be increased to 8 pg/kg/min to achieve blood pressures in the desired range. Hct was measured initially and repeated with the last blood gas determination in each patient.
Plasma dopamine and norepinephrine measurements. These studies were performed in a separate group of 14 preterm neonates requiring continuous positive airway pressure or intermittent mandatory ventilation and 2 and/or 4 pg/kg/min dopamine therapy for systemic hypotension and mildly decreased Uv (UV = 0.027 i 0.012 mL/min/kg) during the first 4 d of life. Plasma dopamine clearance rate (L/kg/min) was calculated as infusion rate (prnol/L/kg/min)/[steady state dopamine concentration (pmol/L) -baseline dopamine concentration (pmollL)] assuming no change in endogenous dopamine secretion. Changes in blood pressure were followed by oscillometry. Four-to 6-h urine collections were obtained during the control period and during dopamine therapy after blood pressures had normalized. To obtain control measurements, plasma dopamine and norepinephrine levels were also determined and plasma dopamine clearance rate was calculated in five children presenting with mild renal diseases and normal renal functions. Clinical data of the preterm infants and children enrolled in this segment of the study are summarized in Table 3 .
In 14 infants, 20 baseline samples for plasma dopamine and norepinephrine measurements were drawn to determine whether significant spontaneous fluctuations in baseline catecholamine samples were analyzed for plasma dopa'mine and norepinephrine determinations, respectively (DA-4 data). In six patients, DA-2 and DA-4 norepinephrine levels were determined without corresponding dopamine level measurements.
In the five children, 1 1 baseline samples for plasma dopamine and norepinephrine determinations were drawn (control data). Dopamine was then started at 2 pg/kg/min and 19 samples were analyzed for plasma dopamine and norepinephrine levels (DA-2 data). Blood samples were taken through a peripheral cannula placed before the study to avoid possible stress-induced changes in plasma catecholamine levels.
A maximum of seven samples, for a total of 4.2 mL of blood, were removed from each patient. In the preterm infants, it was replaced incrementally with cross-matched packed red blood cells. The samples were immediately transferred to specially prepared ice-cold test tubes, mixed, and centrifuged at 4"C, and the plasma was separated and kept frozen at -70°C until analysis. Plasma dopamine and norepinephrine levels were determined by radioenzymatic assay (29) . The sensitivity of the assay was 1.96-2.6 1 and 0.15-0.3 nmol/L for dopamine and norepinephrine, respectively. Intraassay and interassay coefficients of variation were <5% and <lo%, respectively.
Statistical analysis. Data collected are given as means f SD unless indicated otherwise. Paired and unpaired t test, simple regression analysis, and one-factor ANOVA (Scheffe F test or Fischer's protected least squares difference test) were used for statistical analysis of the data where applicable. p < 0.05 was considered significant. Table 4 and Fig. 1 , p < 0.05 versus the control and DA-2 groups). No significant difference was seen in heart rate among the groups before and during dopamine treatment. Furthermore, heart rate did not change significantly within the groups during the study. -so
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In the moderately hypotensive term neonates, the PI was in o the normal range (-65 to 75%) during the control period ( Table 4 . SBP and DBP (mm Hg) in preterm neonates requiring and DA-4 group; no dopamine therapy (control group) and in preterm infants treated with 2 and 4 ~g/kg/min dopamine (DA-2 and DA-4 the three term infants in whom complete sets of measurements group, respectively) before (baseline) and during were obtained. ESFV and EDFV also did not change during the drug infusion (DA) study.
Control
DA-2 DA-4
In the hypotensive preterm neonates, the PI was also in the grou P group group normal range (-65 to 75%) during the control period (Fig. 2, (n = 20) (n = 31) (n = 10) lower panel). Infusion of 2 rg/kg/min dopamine tended to increase the SBP and DBP. However, only the increase in SBP and EDFV account for the change in PI, CBF was elevated $ p < 0.05 vs baseline SBP/DBP in control group and during DA during this period (27, 28) . Although the elevation in blood pamine and norepinephrine levels, and plasma dopamine clearance rates during the study. Control dopamine levels were below the sensitivity of our assay (<2.61 nmol/L). In the preterm infants, steady state plasma dopamine levels with 2 pg/kg/min dopamine infusion were significantly higher than those with the same infusion rate in the children. In the preterm neonates, doubling the dose of dopamine resulted in a 60% increase in steady state plasma dopamine levels. In agreement with earlier reports (30, 3 I), baseline plasma norepinephrine levels were significantly elevated in the preterm infants compared with those in the children. Administration of 2 pg/kg/min dopamine resulted in significant elevations in plasma norepinephrine levels in both groups. However, 4 pg/kg/min dopamine did not cause any further increase in plasma norepinephrine in preterm neo- . Control D A -2 PI, ESFV, and EDFV returned to control levels by 50 to 90 min after the initiation of drug infusion (at DA-2/60).
To achieve and maintain blood pressures in the predicted normal range (25, 26) , the dose of dopamine was increased to 4 pg/kg/min in three of the preterm infants and to 8 pg/kg/min in the remaining two preterm neonates. Both SBP and DBP increased significantly. At -20 min after the initiation of the higher doses (DA-4/20), PI again significantly decreased ( p < 0.05 versus DA-2/60 and DA-4/60) and ESFV and EDFV increased (not shown), indicating a concomitant increase in CBF. Despite the sustained significant elevation in the blood pressure, however, PI, ESFV, and EDFV again returned to normal at DA-4/60.
Efect of 2 and 4 pglkglmin dopamine on plasma catecholamine levels. In this group of preterm infants, SBP increased significantly from 37. nates. Plasma dopamine clearance rates with 2 pglkglmin dopamine infusion were significantly higher in the children than in the preterm infants. In the preterm infants, plasma dopamine clearance was somewhat higher with 4 pg/kg/min than with 2 pglkglmin of dopamine.
SBP and plasma dopamine concentrations were significantly correlated (r = 0.731, p < 0.05). DBP correlated poorly but significantly with plasma dopamine levels (r = 0.329, p < 0.05) as did SBP with plasma norepinephrine concentrations (r = 0.43, p < 0.05). Finally, in agreement with recent findings (4), we also found a significant but poor correlation between plasma dopamine and norepinephrine concentrations (r = 0.357, p < 0.05).
DISCUSSION
In the present study, we have demonstrated that hypotensive preterm infants during the first days of life exhibit an increased sensitivity to the pressor effects of dopamine. The data also suggest the existence of a fairly mature renal tubular dopaminergic system in the human preterm neonate and underline the importance of the direct tubular actions of the drug. Furthermore, our findings present indirect evidence for changes in the CBF of preterm infants that parallel the alterations in systemic blood pressure and for the presence of an immature but not completely ineffective CBF autoregulation in the human preterm neonate. The observed decreased metabolism of dopamine in the sick preterm neonate during the first days of life may contribute to the enhanced cardiovascular and renal response to the drug.
Our findings indicate that preterm infants on the first days of life, unlike children and adults (6, 7, 10, 11), respond to low doses of dopamine with an increase in blood pressure and no significant changes in heart rate. This difference in response may be related to developmental changes in the sensitivity of adrenergic receptors to dopamine as well as to the maturation of hepatic and renal clearance mechanisms. In children and adults, dopamine, in increasing concentrations, activates the dopaminergic, then the 8-adrenergic, and finally the a-adrenergic recep tors (10) . The present findings and our earlier observations (3, 8, 32, 33) as well as those reported by others (2, 34) suggest that the order of receptor sensitivity is different in the preterm infant, i.e. clinical signs of stimulation of the a-adrenoreceptors and dopamine receptors occur before those of the 8-adrenoreceptors. Thus, the enhanced responsiveness of the preterm infant to the pressor effects of dopamine during the early postnatal period is mainly due to the increased a-adrenergic sensitivity of the immature cardiovascular system (22) . However, the recently documented existence of a positive inotropic response (34) may also play a role in this phenomenon. Furthermore, the decreased clearance rate of dopamine found in the present study in sick preterm neonates may also contribute to their enhanced cardiovascular response to the drug during the first few days of life. Finally, the findings that GFR increases out of proportion to the drug-induced rise in blood pressure and that UUN significantly decreases despite the increase in UV suggest that a fairly mature dopaminergic regulation of renal hemodynamics also plays a role in the observed pattern of cardiovascular response to low doses of dopamine in the preterm neonate (at least beyond the 27th wk of gestation). Consistent with the maturational process, term neonates are less sensitive than preterm infants to the pressor effects of lowdose dopamine therapy. However, according to our present findings, at least on the first day of life, they still exhibit a somewhat enhanced pressor response compared with older age groups (2, 35) .
Our earlier studies provided indirect evidence for the existence of the direct tubular actions of dopamine in the 14-old preterm human neonate (24, 32, 33) . The present findings demonstrate that 2 and 4 pg/kg/min dopamine induce significant but similar increases in UV and sodium excretion in this age group, whereas the higher dose of the drug also results in statistically significant elevations in blood pressure and C, . Thus, while maintaining blood pressure and GFR comparable to those in untreated, normotensive controls, 2 pglkglmin dopamine induces maximum diuresis and natriuresis in the I-d-old mildly hypotensive preterm neonate. Therefore, these findings support our previous observations (24, 32, 33) and demonstrate that the dopamineinduced diuresis and natriuresis also result from the direct tubular effects of the drug.
When explaining the mechanisms of the diuretic and natriuretic actions of dopamine, earlier reports emphasized the importance of the drug-induced cardiovascular and renal hemodynamic changes (10, 1 I, 20) . The importance of the direct tubular actions of dopamine in producing diuresis and natriuresis has only recently been recognized (9, 14) . In the kidney, endogenous and exogenous do~amine inhibit Na'.K'-ATPase (9. 12. 13) and N~+/H+-exchanger (15) activity along the nephron a& ih the proximal tubule, respectively. Furthermore, in the distal tubule, dopamine attenuates the actions of antidiuretic hormone and aldosterone ( 14, 16) . All these tubular actions of dopamine result in decreased sodium and water reabsorption along the nephron and thus lead to significant natriuresis and diuresis (9, 14) . Because our findings demonstrate the presence of the direct tubular effects of dopamine in the preterm neonate, they also imply that functionally mature renal tubular dopamine receptors and postreceptor responses are present in the human preterm infant at least beyond the 27th wk of gestation.
Our findings also provide indirect evidence for the presence of renal hemodynamic actions of dopamine in the I-d-old preterm neonate. The increase in C, with 4 pg/kg/min dopamine indicates a blood pressure elevation-induced rise in GFR without concomitant renal vasoconstriction. Furthermore, the decrease in UUN suggests a dopamine-induced selective enhancement of the medullary circulation ["urea wash-out phenomenon" (24)l. These renal hemodynamic effects of dopamine indicate the presence of functionally mature vascular dopamine receptors and postreceptor responses in the kidney of the I-d-old preterm infant.
The dopamine-induced decrease in free water clearance is most likely the consequence of the increased solute excretion. Although urinary potassium excretion tended to increase, it did not significantly change with either dose of dopamine. Because the excretion of potassium is influenced by many factors mainly of distal tubular origin and independent of the renal dopaminergic system (36) , the immaturity of distal tubular function of the preterm human infant (36) could explain the observed pattern of potassium excretion. The significant increase in phosphate excretion with dopamine treatment results from the direct proximal tubular effects of the drug (36, 37) . Furthermore, because the major constituent of titratable acid in the urine is HzP04-, the significant increase in UTA is most likely the consequence of decreased phosphate reabsorption rather than increased acid production. This assumption is supported by the fact that U N H~ remained unchanged.
In the present study, we also examined whether 2 and 4 pg/ kg/min dopamine, or the drug-induced elevation in blood pressure, would affect CBF in hypotensive term and preterm neonates. Our study design allowed us to evaluate temporal changes in CBF while patients received the same dose of dopamine without further significant changes in their blood pressure.
Pulsed Doppler ultrasound measurements of CBF velocity are considered reliable indicators of CBF provided no significant changes in heart rate and hematocrit occur and the angle of insonation of the ACA is constant during measurements (1 8, 19, 21, 28) . All these criteria were met in our study. Although the technique has its limitations when used as a measure for estimation of the absolute volume of CBF (27) , its use for comparison of serial measurements of CBF velocity provides valuable and reproducible information. We also calculated the PI and used it as a measure of change in CBF velocity (27, 28) . Changes in the PI are inversely and significantly related to changes in CBF in human preterm and term neonates (28) . Use of PI for serial comparisons of CBF velocity is a simple, descriptive, and valuable way to characterize changes in CBF (27, 28) provided that the alterations in ESFV and EDFV account for changes in PI (27) , as was the case in our study.
Within the observed blood pressure range and at least 15 min after the initiation of dopamine infusion, we found an intact autoregulation of CBF in the moderately hypotensive term infants. However, as indicated by the decrease in PI and increase in ESFV and EDFV in the hypotensive preterm neonates, the dopamine-induced increase in blood pressure was associated with a temporary elevation in CBF. Effective autoregulation of CBF in preterm neonates occurred only 50 to 90 min after the start of the dopamine infusion.
If dopamine had a direct, selective vasodilatory effect on the cerebral vasculature, one would expect to see sustained increases in CBF occur independently of changes in systemic blood pressure. The lack of a sustained increase in CBF suggests the absence of a significant selective vasodilatory effect of dopamine on the cerebral vasculature in the human preterm infant. Furthermore, no alterations in heart rate, blood gases, and Hct that could have influenced CBF independently of the dopamine-induced blood pressure changes occurred during the study.
Although in our hypotensive patients the PI during the control period was in the predicted "normal" range for both preterm and term infants (27, 28) , it is not known whether their absolute CBF was indeed normal. Our findings only demonstrate the alterations in CBF, and they indicate that even small changes in systemic blood pressure may temporarily and adversely influence cerebral perfusion in sick preterm infants.
Finally, we measured plasma dopamine and norepinephrine levels and calculated plasma dopamine clearance rates in 1-to 44-old preterm infants and compared the findings with those obtained in 5-to 15-y-old children with normal liver and kidney functions receiving 2 pg/kg/min dopamine infusions. Several other studies have recently been published on the dopamineinduced changes in plasma catecholamine levels in infants, children, and adults (4, 34, (38) (39) (40) . However, data on preterm infants are scanty and, in most of the studies, findings in preterm infants are grouped together with those in term neonates (4, 34, 40) . The studies agree that there is a significant variability among patients in plasma dopamine levels during dopamine infusion (4, 34, 39, 40) . It is also accepted that steady state plasma dopamine levels are uniformly increased in the presence of liver and/or kidney failure (39) . Because -20% of the infused dovamine is converted to norepinephrine, and dopamine also triggers the release of stored nore~ine~hrine. a linear relations hi^ between plasma dopamine a i d norepindphrine exists in adulis and children (4, 38) . However, sick preterm infants with significantly increased sympathetic activity may not exhibit a dosedependent increase in plasma norepinephrine during dopamine infusion (34) .
We found that, in children, steady state plasma dopamine levels and plasma dopamine clearance rates were within the reported range for adults (38) . Furthermore, although baseline plasma norepinephrine levels were at the upper end ofthe normal range, plasma norepinephrine levels increased as expected with dopamine administration.
Consistent with earlier reports (30, 3 l), baseline plasma norepinephrine levels in the preterm infants were higher than those in the children. Steady state plasma norepinephrine levels rose during 2 pg/kg/min dopamine administration but not with 4 pg/ kg/min drug infusion. The lack of a further rise in plasma norepinephrine concentration with the higher dose may be explained by the significantly elevated baseline sympathetic activity in these infants (4, 30, 34) . We found significantly lower plasma dopamine clearance rates with 2 rg/kg/min dopamine in the preterm neonates than in the children. In the preterm infants, the steady state plasma dopamine levels were comparable to those obtained with the same doses in sick infants and children with liver and/or renal dysfunction (39) . It has also been suggested that sick preterm neonates may have decreased plasma dopamine clearance rates during the first days of life (40) . Therefore, the elevated steady state plasma dopamine concentration in our sick preterm neonates is most likely the consequence of their impaired metabolic function due to their early postnatal age and severe underlying disease.
In the present study, we have found that hypotensive preterm infants during the first days of life exhibit an increased sensitivity to the pressor effects of dopamine. Based on our findings, we suggest that rapid i.v. infusions of colloid and/or crystalloid in the hypotensive and/or oliguric sick preterm infant should be avoided and propose that dopamine infusion should be started early and at low doses (2 pglkglmin). The dose of the drug should be increased slowly and adjusted according to the cardiovascular and renal response of the patient. The observations that sudden and significant changes in systemic blood pressure, and thus in CBF, may contribute to the development of IVH during the first days of life (18) lend further support to these suggestions. However, treatment of systemic hypotension using this approach should not be delayed, because decreased tissue perfusion of the brain will have devastating long-term consequences ( 17) .
